Field of Science

Blogging will be slow

I am finishing up my graduate work and moving on to a postdoc up in the chilly northeast. Detailed location best undisclosed for now. Blogging will therefore be slow, although I hope to toss out some erudite nonsense about the graduate school experience soon.

A Drug Design Class Act: ∆S or ∆H?

Image Hosted by ImageShack.us


ResearchBlogging.org

One of the most important relations in all of chemistry is the free energy relation ∆G = ∆H - T∆S. Tuning the potency of a ligand binding to a protein involves a fine balance between optimizing both entropy and enthalpy. In his review on the role of these two variables, Johns Hopkins's Ernesto Freire makes a very interesting observation; that for a given series of progressively improved set of drugs binding to a given protein, it's the enthalpy that becomes more and more favourable while the entropy pretty much starts out being favourable. Thus, it's enthalpy optimization that's the harder part in drug design.

Freire illustrates his observation by looking at two sets of famous drugs- HIV protease inhibitors and cholesterol-lowering statins. For example if we look at the progression of the protease inhibitors over time starting from about 1995 when we had good but not highly-potent drugs to about 2006 when we had greatly improved drugs, we essentially find the striking fact that while ∆S for drug binding was favourable to begin with in 1995, it's really a great improvement in ∆H that has made the drugs more potent through the years.

Thus Freire concludes that it's improving enthalpy of binding and not entropy that's the hard part in improving potency. The argument is fairly straightforward; favourable entropy depends on desolvation of the drug to get rid of water molecules, as well as displacement of water molecules from the active site by the drug. Both these events are more or less favourable for most drugs as most drugs are reasonably hydrophobic. Thus, high hydrophobicity can by itself confer favourable entropy. But tuning enthalpy is much harder for two reasons; first of all because as Freire notes, it is not possible yet to engineer hydrogen bonds to the tenths of angstroms needed for optimum energetic gain. Secondly, even a slight sub-optimal feature in hydrogen bonding can tip the scales because remember, the hydrogen bonds that the ligand forms with the protein are simply replacing strong hydrogen bonds that were previously formed with the surrounding water. Thus the new hydrogen bonds may not be as strong, and indeed may even be unfavourable with respect to the previous ones. From past discussions, recall that a mere 1.4 kcal/change in free energy from unfavourable hydrogen bonding can lead to a 10-fold loss in binding affinity ("Life is a 3 kcal/mol denizen"). Clearly one has to be careful while designing ligands to form hydrogen bonds. It's perhaps not surprising that hydrophobic effect-induced binding is the main stabilizing factor in both protein folding and ligand design; both man and nature apparently find it much easier to get binding affinity from hydrophobic interactions than polar ones.

These facts are borne out when we see the change in these two thermodynamic variables in the optimization of HIV protease inhibitors over time where, while ∆S is favourable to begin with, ∆H is actually positive and unfavourable at the beginning. Let's also not forget that potency is only the beginning for a ligand that needs to traverse many obstacles in order to be converted into a drug, including ADME-T optimization. Any one of these further modifications can modify the one or both of the thermodynamic variables and change the initially optimized potency.

However, since optimizing enthalpy is both more challenging and more important, Freire prescribes experimentally measuring the two variables as much as possible for every stage of the drug design process starting as early as possible. This can be best accomplished through Isothermal Titration Calorimetry (ITC) which can also shed light on enthalpy-entropy compensation, an important process in the binding of ligands.

Thermodynamic optimization is a tightrope walking act, a prelude to the ultimate juggling game that is drug design. Not only are you trying to balance several variables at once, but some of them are trying to actually pull you down. But simple strategies can quell at least some of these nefarious efforts and reward you with a fine ligand, if not drug.

Reference:
E Freire (2008). Do enthalpy and entropy distinguish first in class from best in class? Drug Discovery Today, 13 (19-20), 869-874 DOI: 10.1016/j.drudis.2008.07.005

Some slices from the literature

ResearchBlogging.org

Not too much time this week to dwell in detail on papers, but here are some that I found interesting:

Richard Friesner and his colleagues at Columbia investigate the entropic contribution of arginine side chains by measuring local conformational dynamics by NMR spin relaxation. They compare these results to detailed MD simulations to infer that the aliphatic side chain maintains enough entropy for the charged amino group to fruitfully engage in rigid salt-bridge formation, thus minimizing the entropic penalty.

On the other side of the Atlantic, Angelo Vedani and his colleagues in Basel have derived a QSAR model for psychotropic drugs binding to the glucocorticoid receptor using their programs Yeti and QUASAR. The GR is a nuclear hormone receptor that can modulate a variety of key processes by binding small molecules. The model was validated on 110 compounds representing 4 chemical classes.

An interesting paper on the conformation of a common and important consensus tripeptide motif in a glycoprotein compares measured IR intensities and frequencies using a technique called ion-dip IR spectroscopy to frequencies calculated using high-level ab initio theory (MP2/6-311++G**). The Oxford authors do the comparison for the wild type motif as well as for two mutants and ask a "Why nature selected this specific motif" kind of question by looking at the viability of the resulting conformations. It looks fine, but I am a little skeptical about all those gamma turns that they see, a common artifact of inadequate treatment of solvation in both force field and ab initio approaches.

And again on the medicinal front, a group in Europe does some fragment-based computational design and find a PPAR agonist. Detailed knowledge of protein structure aids in explaining why one bioisostere works and another one does not.

Author's delight

Now this is the kind of comment that I look forward to from a reviewer:
"Referee's report: This paper contains much that is new and much that is true. Unfortunately, that which is true is not new and that which is new is not true."

In H. Eves, Return to Mathematical Circles, Boston: Prindle, Weber, and Schmidt, 1988.
Another memorable comment was kindly passed on to me by Prof. Tony Barrett of Imperial College, London.
"This paper should be reduced by 50% and oxidised by 150%"- Anon

PBS film on Oppenheimer

I accidentally came to know about this film about Oppenheimer on American Experience on PBS yesterday. It was a 2 hour piece, a docu-drama, with David Strathairn playing Oppenheimer during his infamous trial. The trial was an opportunity for Oppenheimer to recapitulate his life, and this is what the docu-drama does. It would undoubtedly be repeated and I would strongly encourage those unfamiliar with the man and the period in this country's history to watch it. It shows the rise of a truly brilliant and iconic character, followed by his fall that was orchestrated by a vindictive and self-serving government.

Given my long interest in Oppenheimer, there wasn't much in the film that was new for me. It was highly informative, poignant and fortunately well-grounded in facts and consensus. Interviewed among others were historians Richard Rhodes, Martin Sherwin, Priscilla McMillan and veteran scientists Harold Agnew, Herbert York, Nobel Laureate Roy Glauber and Marvin Goldberger. Prudently, the film does not speculate on Gregg Herken's belief that Oppenheimer was a member of the communist party; to my knowledge only Herken holds this opinion, and to be honest it does not even matter. But as the record shows, 30 years of constant investigation by the FBI turned up nothing that indicated party membership, and that says a lot.

The disturbing thing about the trial of course is that it is a poster boy case for how disagreement and dissent are equated with disloyalty by the government, a tale for our times even as its essential unlawful scare tactics have been repeated in numerous administrations, and most recently in the Bush administration when opposition to the Iraq war was often deemed "unpatriotic". The Oppenheimer story, one of the most shameful episodes in this country's history in my opinion, is a cautionary tale that should always be remembered as an example of how we need to be constantly alert and aware in a democracy and watch out for abuse of power by the government. The film does a good job of demonstrating this.

Fundamentals of Asymmetric Catalysis

Image Hosted by ImageShack.us
source

Fundamentals of Asymmetric Catalysis
Patrick Walsh and Marisa C. Kozlowski
University Science Books, 2008

I browsed this yesterday in the library and it looks really good. An opinion from one of the field's godfathers:
It is my opinion that this text will be widely accepted by the organic chemical community. There is nothing like it currently on the market. It reminds me of the Morrison & Mosher text, Asymmetric Synthesis, that was published more than three decades ago. The authors have generated the New Bible of asymmetric catalysis. The results are truly impressive and the cases are both relevant and current. --David A. Evans, Harvard University

A beautiful, informal and comprehensive account of quantum history

Uncertainty: Einstein, Heisenberg, Bohr, and the Struggle for the Soul of Science
David Lindley
Anchor, 2008

One of the best informal histories of quantum physics and its makers that I have come across, and I can say I have read many. Concisely and with passionate enthusiasm, Lindley manages to weave together the essential scientific discoveries, the scores of anecdotes about the famous participants including their personal conflicts and friendships, the philosophical and social implications associated with many quantum concepts, and the political and historical turmoil and connections that accompanied these discoveries. While mainly focused on Einstein, Heisenberg and Bohr, Lindley draws vivid portraits of other pioneers such as Pauli, Dirac, Born, Kramers and Schrodinger. Quantum physics is perhaps the most paradoxical, beautiful, bizarre and important scientific paradigm ever developed. The decade from 1920-1930 was undoubtedly the golden era of physics. Lindley succinctly and engagingly tells us how and why. A must read for history of physics lovers.

Strain Energies in Ligand Binding: Round Two- Fight!

Or why to be wary of ligands in the PDB, force field energies, and anybody who tells you not to be wary of these two

ResearchBlogging.org

One of the longstanding questions in protein-ligand binding has been; what is the energy penalty that a protein has to pay in order to bind a ligand? Another question is; what is the strain energy that a protein pays in order to bind the ligand? Contrary to what one might initially think, the two questions are not the same. Strain energy is the price paid to twist the conformation of the ligand into the binding conformation. Free energy of binding is the energy that the protein has to pay in addition to the strain energy in order to bind the ligand.

A few years ago, this question shot into the limelight because of a publication in J. Med. Chem. by Perola et al. from Vertex. The authors did a meticulous study of hundreds of ligands in their protein-bound complexes, some from the PDB and others proprietary. They used force fields to estimate the difference between the energy of the bound conformation of the ligands and the nearest local energy minimum conformation- the strain energy penalty. For most ligands, they obtained strain energies ranging from 2-5 kcal/mol. But what raised eyebrows was that for a rather significant minority of ligands, the strain energies seemed to be more than 10 kcal/mol, and for some they seemed to be up to 20 kcal/mol.

These are extremely high numbers. To understand why this is so, consider a fact that I have frequently emphasized on this blog; the concentration of a particular conformation in solution is virtually negligible if the free energy difference between it and a stable conformation is about only 3 kcal/mol. For a conformation to pay that much of an energy penalty in order to transform itself into the bound conformation would already be a stretch, considering its low concentration. For a conformation to pay an energy penalty of 20 kcal/mol does not make sense at all in this light, since such a conformation should be non-existent. Plus, think about the fact that hydrogen bonds usually contribute about 5 kcal/mol and that energy at room temperature is itself about 20 kcal/mol- significantly greater than the rotational barriers in most molecules- and this number for the strain energy penalty starts looking humungous. Where exactly would it come from?

Perola's paper generated a lot of buzz- a good thing. It was discussed by speakers at a conference in March last year that I attended. Now, a paper in J. Comp. Chem. seems to clear up the air a little. In a nutshell, the authors conclude that the strain energies they have measured seldom, if ever, surpass 2 kcal/mol. Needless to say, this is a huge difference compared to the earlier studies.

Why such a startling difference? It seems that as always, the answer strongly depends on the method and the data.

First of all, the PDB is not as flawless as people assume it is. Most people who are crystallizing protein-ligand complexes are first and foremost interested in the structure of the protein. They often do a poor job of fitting ligands to the electron density; Gerard Kleywegt of the University of Uppsala has done some marvelous work on detecting errors in PDB ligands, and his review on this should be a must-read for all scientists even marginally connected with crystallography. Because of poor fits, conformations of ligands in the electron densities in the PDB can be completely unrealistic and at the very least, brutally strained. Amides can be cis or non-planar, and more rarely planar aromatic rings can be deformed. There can be severe steric clashes which are not easily apparent. Quite naturally, such conformations when refined would lead to huge drops in energy. Therein lies the first source of the unrealistically large strain energy differences.

The second factor has to do with the vagaries and inadequacies of force fields, often unknown to crystallographers but known to experienced computational chemists. Force fields are quite poor at determining energies and their results are especially skewed by an overemphasis on electrostatic interactions which the force fields are ill-equipped to damp. Now consider what happens when a ligand in a PDB that has a positively and negatively charged group in it is optimized. If you relax it to the nearest local energy minimum, these two groups would instantly snap together and form a very strong ionic bond. This would lead to a huge overstabilization of the conformation, thus again giving the illusion of a large strain energy difference between the PDB conformation and the local minimum.

Finally, the devil is in the details. In doing the initial refinement of the conformation, the earlier study used a constraint called the flat-bottom potential in optimizing the PDB ligands in their bound state. However the flat-bottom potential, which extracts no penalties for atomic movement within a certain short distance and suddenly ramps up the penalty, is not physically realistic. A better method might be to use a harmonic potential which continuously and smoothy extracts a penalty proportional to atomic displacement.

The present study takes all these factors into account and also substitutes the force field results with some well-established quantum chemical energy determinations at the B3LYP/6-31G* level. They use this method to calculate the energies of bound and local energy minimum conformations. Secondly, they use a well-established continuum solvation model (PCM) as incorporated in the latest version of the Gaussian program to incorporate damping effects due to solvation. Thirdly as indicated above, they use the harmonic potential for optimization. Fourthly and most importantly, for the cases where the strain energy seems unusually high (and even there they set the bar quite high- anything greater than 2 kcal/mol), the authors closely investigate the relevant PDB entries and find that indeed, the ligands were not fit well into the electron density and had unrealistically strained conformations.

Once they tackled these problems, the strain energies all fell down to between 0.5 and 2 kcal/mol, which seems to be a realistic penalty that a conformation with a respectable concentration in solution could pay. There is now a second question; what is the maximum strain energy penalty that a ligand can pay to be transformed into the bound conformation? The authors are working on this question, and we will await their answer.

But this study reiterates two important lessons that should be remembered by anyone dealing with structure at all times:
1. Don't trust the PDB
2. Don't trust force field energies

Better still, as old Fox Mulder said, trust no one and nothing.

References:
1. Keith T. Butler, F. Javier Luque, Xavier Barril (2009). Toward accurate relative energy predictions of the bioactive conformation of drugs Journal of Computational Chemistry, 30 (4), 601-610 DOI: 10.1002/jcc.21087

2. Emanuele Perola, Paul S. Charifson (2004). Conformational Analysis of Drug-Like Molecules Bound to Proteins: An Extensive Study of Ligand Reorganization upon Binding Journal of Medicinal Chemistry, 47 (10), 2499-2510 DOI: 10.1021/jm030563w

3. A Davis, S Stgallay, G Kleywegt (2008). Limitations and lessons in the use of X-ray structural information in drug design Drug Discovery Today, 13 (19-20), 831-841 DOI: 10.1016/j.drudis.2008.06.006

This is how science should be taught

The Viki Weisskopf way

From Jeremy Bernstein's review of noted physicist Victor Weisskopf's 1991 memoir. Bernstein first took a class from the utterly brilliant and impenetrable Nobel laureate Julian Schwinger at Harvard. After a couple of days of withstanding the barrage, Bernstein decided to attend Victor Weisskopf's class at MIT. The result is endearingly described:
My visits to Viki's class in quantum mechanics at MIT were, in every way, a culture shock. The class and the classroom were both huge—at least a hundred students. Weisskopf was also huge, at least he was tall compared to the diminutive Schwinger. I do not think he wore a jacket, or if he did, it must have been rumpled. Schwinger was what we used to call a spiffy dresser.

Weisskopf's first remark on entering the classroom, was "Boys [there were no women in the class], I just had a wonderful night!" There were raucous catcalls of "Yeah Viki!" along with assorted outbursts of applause. When things had quieted down Weisskopf said, "No, no it's not what you think. Last night, for the first time, I really understood the Born approximation." This was a reference to an important approximation method in quantum mechanics that had been invented in the late 1920s by the German physicist Max Born, with whom Weisskopf studied in Göttingen. Weisskopf then proceeded to derive the principal formulas of the Born approximation, using notes that looked as if they had been written on the back of an envelope. Along the way, he got nearly every factor of two and pi wrong. At each of these mistakes there would be a general outcry from the class; at the end of the process, a correct formula emerged, along with the sense, perhaps illusory, that we were participating in a scientific discovery rather than an intellectual entertainment. Weisskopf also had wonderful insights into what each term in the formula meant for understanding physics. We were, in short, in the hands of a master teacher
The trick in any class is not to let the students know how much you know (the Schwinger technique) but to let them know how much you, and indeed everyone else, do not know.

The wrath of lithium

Mitch alerts us to this extremely tragic story where a UCLA lab assistant has succumbed to burns caused by t-butyl lithium:
A 23 year old female research associate/laboratory technician intended to add an (unknown) aliquot of 1.6 M t-bu-Li (in pentane) to a round bottom flask, placed in a dry ice/acetone bath. She had been employed in the lab for about 3 months. The incident occurred on Dec. 29, during the UCLA holiday shutdown between Christmas and New Years. Researchers are granted permission to work during the shut down for “critical research needs.” There were two post doctoral researchers working in the lab and the adjacent lab, with limited English proficiency.

The principal investigator had trained the employee to slightly pressurize the bottle (an ~ 250 ml Aldrich Sure Seal container) with Argon and withdraw the desired aliquot using a 60 ml syringe, fitted with a 20 gauge needle. The PI likes to use these particular syringes because they have a tight seal. There is no evidence that the employee used this method. Speculation: she may have just tried to pull up the aliquot in the syringe. Somehow, the syringe plunger popped out or was pulled out of the syringe barrel, splashing the employee with t-bu-Li and pentane. The mixture caught fire, upon contact with air. She was wearing nitrile gloves, safety glasses and synthetic sweater. She was not wearing a lab coat. The fire ignited the gloves and the sweater.

Six feet from the fume hood was an emergency shower. When the employee’s gloves and clothing caught fire, she ran from the area away from the shower. One of the post-docs used his lab coat to smother the flames. 911 was called. UCLA Fire Dept. and emergency medical, Los Angeles City Fire, and Los Angeles County Haz Mat. The EMTs put the employee in the safety shower for gross decon and then transported her to the ER. She’s currently in the Grossman burn unit in Sherman Oaks with second degree burns on her arms and third degree burns on her hands, a total of about 40% of her body. There was very little damage to the lab. Bill has not interviewed the employee.
I find it especially sad that she was doing a relatively routine procedure done in hundreds of labs, and was wearing gloves and safety goggles, even if not a lab coat. This sobering incident should remind us that for all that we jest about laboratory procedures and reagents, working in a lab should be a deadly serious activity. Sometimes the monotony blurs the line between casual protocol and hellishly serious work precautions.